ロード中...
Chronic myeloid leukemia: sequencing of TKI therapies
Multiple tyrosine kinase inhibitors (TKIs) are available for managing patients with chronic myeloid leukemia. Although most patients have a favorable outcome with their initial therapy, whether imatinib or a second-generation TKI was used, some will require subsequent use of one or more different TK...
保存先:
| 出版年: | Hematology Am Soc Hematol Educ Program |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142480/ https://ncbi.nlm.nih.gov/pubmed/27913476 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|